| Oratect III Oral Drug Screen
#HM11: (COC, THC, OPI, AMP, mAMP, PCP) Box of 25
The Oratect III is a on-site oral drug screen that uses oral fluid to detect the presence of up to 6 drugs. Oratect III is simple non-invasive and rapid one step drug screen procedure. Oratect III detects parent drugs instead of metabolites. The Oratect III oral drug screen device is a one-step chromatographic immunoassay device for the qualitative simultaneous detection of multiple drugs. Oratect III Rapid 6 panel saliva screen. The Oratect III Oral Drug Screen Device introduces a blue line indicator for the sufficient collection of saliva. The presence or absence of a red line corresponding to a specific drug on the panel indicates a negative result or presumptive positive result respectively. Oratect III onsite Oral Drug Screen allows testers to obtain the rapid results they need without having the concerns of handling a urine specimen.
The Oratect III Oral Drug Screen Device is based on a competitive immunoassay procedure in which drug derivatives immobilized on the membrane compete with the drug(s) which may be present in the oral fluid for limited antibody binding sites on the colored colloidal gold antibody conjugate. During screening, saliva is collected at the collection pad and migrates across the membrane. This is indicated by the movement of the blue lines. If no drug is present in the oral fluid, the colored colloidal gold antibody conjugate will bind to the drug derivatives on the membrane to form visible bands at specific test regions. Any presence of a colored band at a specific test region indicates a negative result. The absence of a color band at the test region indicates a presumptive positive result for the particular test. In either case, a color band at the control region (C) must appear and it indicates that the test has performed properly. If the control band does not appear, the test results are invalid and must be repeated with a new device.
The Oratect III Oral Drug Screen is designed and calibrated to be interpreted 5 minutes after starting the saliva collection procedure. Waiting longer than 10 minutes may result in erroneous results or false positive results. The Oratect III is highly sensitive to the presence of drugs. The Oratect III Oral Drug Screen Device is designed for the qualitative detection of drugs of abuse in human saliva. It is a one-step lateral flow immunoassay device for the qualitative detection of methamphetamine, MDMA, THC, cocaine, amphetamine, opiates, phencyclidine or benzodiazepines in human oral fluid. Illegal drugs contribute to many accidents, injuries and medical conditions. Screening individuals for drugs of abuse is an important method in identifying those who may cause harm to themselves and to others. Studies on methamphetamine, MDMA, cocaine, opiate, amphetamine, phencyclidine, benzodiazepine, cannabinoid show that all of them are detectable in oral fluid. Oratect III Oral Drug Screen Device is designed to integrate oral fluid collection and simultaneous screening for drugs-of-abuse. |
